Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Hui Zhu et al.|Cancer Research|2022Cited by 106
ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancerTin Lok Wong, Stephanie Ma|Nature Communications|2023Cited by 96
Data from Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Carmen Oi Ning Leung et al.|Unknown|2023Cited by 0
Supplementary Data from Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Carmen Oi Ning Leung et al.|Unknown|2023Cited by 0
Supplementary Data from Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Carmen Oi Ning Leung et al.|Unknown|2023Cited by 0